Handelsavisen
prelaunch
Companies Healthcare MEM.AX
ME
MEM.AX ASX Advanced Medical Equipment & Technology

Mem.Ax

A$0,01
Open in Charts → Attach watcher ⌖
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
17,1M AUD
P/E
EV / Rev
Div yield
Op margin
-120 505,9 %
ROE
-116,1 %
Net margin
-136 191,4 %
Debt / equity
1,20
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

MEM.AX operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies for healthcare applications.

Business. MEM.AX operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies for healthcare applications.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-116,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning MEM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to MEM.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    MEM.AX operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and technologies for healthcare applications.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    MEM.AX has a market price of 0.005 AUD and a market capitalization of 14,236,168.71 AUD, indicating a small-cap profile. The company's price-to-book ratio is 3.28, and its price-to-tangible-book ratio is also 3.28, suggesting that the market is valuing the company's equity at a premium relative to its book value. The enterprise value to EBITDA ratio is -4.36, and the enterprise value to revenue ratio is 5,253.67, both of which are significantly negative and high, respectively, indicating poor profitability and a high valuation relative to revenue.

    The company's profitability metrics are concerning. The return on equity is -1.16, and the return on assets is -0.45, both of which are negative, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. The debt-to-equity ratio is 1.2, and the current ratio is 0.2, suggesting that the company has a high level of debt relative to equity and limited short-term liquidity to cover its current liabilities.

    The company's capital structure is heavily leveraged, with long-term debt amounting to 5,202,410 AUD and total liabilities of 6,870,110 AUD. The company's total equity is 4,341,650 AUD, and the debt-to-equity ratio of 1.2 indicates that the company is financed more by debt than by equity. The company's liquidity position is weak, with a current ratio of 0.2, indicating that it has only 0.2 AUD in current assets for every 1 AUD in current liabilities.

    The company's operating performance is poor, with a gross profit of -35,590 AUD, an operating income of -4,458,720 AUD, and a net income of -5,039,080 AUD. The company's operating cash flow is -2,401,330 AUD, and its free cash flow is -5,192,510 AUD, indicating that the company is not generating positive cash flows from its operations. The company's capital expenditure is -819,730 AUD, suggesting that it is not investing in its operations.

    The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key flag is that the company has negative net cash after subtracting total debt, indicating a liquidity constraint. The company's financial position is weak, with a high level of debt and negative cash flows, which could pose a risk to its ability to meet its obligations.

    The company's recent financial performance and risk profile suggest that it is facing significant challenges. The company's negative profitability metrics, high debt levels, and weak liquidity position indicate that it is not in a strong financial position. The company's ability to generate positive cash flows and improve its profitability will be critical to its long-term viability.

    Key takeaways
    • MEM.AX has a weak financial position with a high debt-to-equity ratio and negative profitability metrics.
    • The company's liquidity position is poor, with a current ratio of 0.2 and negative net cash after subtracting total debt.
    • The company's valuation metrics, such as the enterprise value to EBITDA and enterprise value to revenue ratios, are significantly negative and high, respectively.
    • The company's operating performance is poor, with negative gross profit, operating income, and net income.
    • The company's risk profile is characterized by medium liquidity risk and low dilution risk.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    A$0,01
    Market cap
    A$14.2M
    Enterprise value
    A$19.4M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    3.3x
    P / Tangible book
    3.3x
    Tangible book
    A$4.3M
    Net cash
    -A$5.2M
    Current ratio
    0.2
    Debt / equity
    1.2
    ROA
    -44.9%
    ROE
    -1.2%
    Cash conversion
    48.0%
    CapEx / revenue
    -221.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-120 506,0 %Bottom quartile
    Net Margin-136 191,4 %Bottom quartile
    ROE-116,1 %Bottom quartile
    Capex / Rev-22 154,9 %Bottom quartile
    D/E1,20Bottom quartile
    Cash Conv0,48Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • MEM.AX Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    3.6Kshares short+2.7% vs prior
    1.13days to cover
    5.6%short of daily vol
    518fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    MEM.AXCanonical
    ASX · AUD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage